Overweight and obesity may be a new challenge in the care of patients with oropharyngeal squamous cell carcinoma (OPSCC) and oral cavity squamous cell carcinoma (OCSCC), a new study published online ahead of print in the journal Supportive Care in Cancer has suggested.1

Because the incidence of human papillomavirus (HPV)-related head and neck cancer has been increasing and treatment regimens have been changing, researchers sought to evaluate whether treatment-related weight changes in patients with head and neck cancer has also been evolving.

For the retrospective cohort study, researchers analyzed data on pre- and posttreatment body weight, demographics, medical history, and treatments from 290 patients with OPSCC or OCSCC who received initial definitive treatment at the University of Pennsylvania.


Continue Reading

Results showed over 70% of patients with OPSCC and OCSCC were overweight or obese at all pre- and posttreatment assessments. Researchers found that patients with OPSCC had a 6.63-kg higher average weight than patients with OCSCC at all assessments (P=.002).

After adjusting for potential confounding factors, the study demonstrated that patients who underwent a primary operation had significantly more weight gain from pretreatment to posttreatment follow-up compared with those who underwent primary radiotherapy and/or chemotherapy (P=.041).

Further study is needed to evaluate whether exercise and nutritional interventions can improve their survivorship,” the authors conclude.

REFERENCE

1. Zhang Z, Brown JC, O’Malley BW, et al. Post-treatment weight change in oral cavity and oropharyngeal squamous cell carcinoma [published online ahead of print December 1, 2015]. Supp Care Cancer. doi:10.1007/s00520-015-3029-6.